XML 86 R75.htm IDEA: XBRL DOCUMENT v3.22.4
Note 16 - Stock Option and Purchase Plans (Details Textual) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant 2,895,771 3,429,771
Share-Based Payment Arrangement, Expense $ 683,000 $ 491,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value $ 1.67 $ 1.97
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period 138,900 687,500
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value $ 176,000 $ 1,907,000
Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $ 1,141,000  
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition 1 year 8 months 12 days  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value $ 285,000 515,000
The 2015 Omnibus Plan [Member]    
Share Based Compensation Arrangement By Share Based Payment Award Award Lapsing Restrictions Period 3 years  
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period 5 years  
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period 3 years  
Share-Based Payment Arrangement, Option [Member] | The 2015 Omnibus Plan [Member]    
Common Stock, Capital Shares Reserved for Future Issuance 3,476,021  
Share-Based Payment Arrangement, Option [Member] | The 2020 Omnibus Plan [Member]    
Common Stock, Capital Shares Reserved for Future Issuance 4,596,271  
Restricted Stock [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value $ 0 $ 0